739
Participants
Start Date
March 24, 2022
Primary Completion Date
September 24, 2024
Study Completion Date
January 9, 2026
Pembrolizumab/Vibostolimab
Co-formulation of pembrolizumab 200 mg/20 mL vial and vibostolimab 200 mg administered as IV infusion for up to 35 administrations
Carboplatin
Carboplatin 10 mg/ml administered as IV infusion Q3W for 4 administrations
Cisplatin
Cisplatin 1 mg/ml administered as IV infusion Q3W for 4 administrations
Paclitaxel
Paclitaxel 6mg/ml administered as IV infusion Q3W for 4 administrations
Nab-paclitaxel
Nab-paclitaxel 100 mg/vial administered as IV infusion Days 1, 8, and 15 of each 21-day cycle for 4 administrations
Pemetrexed
Pemetrexed 500 mg/vial administered as IV infusion Q3W until progression, intolerable adverse event (AE), or participant or physician decision
Pembrolizumab
Pembrolizumab 25 mg/mL administered as IV infusion Q3W for up to 35 administrations
National Taiwan University Hospital-Oncology ( Site 2255), Taipei
Chang Gung Medical Foundation-Linkou Branch ( Site 2251), Taoyuan District
NATIONAL CHENG-KUNG UNI. HOSP. ( Site 2252), Tainan City
Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 2254), Kaohsiung City
Klinik Penzing-2. Lungenabteilung ( Site 0702), Vienna
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 0701), Vienna
Sanatorio Parque ( Site 0205), Rosario
Hospital Provincial del Centenario ( Site 0212), Rosario
Ordensklinikum Linz GmbH Elisabethinen-Department of Pneumology ( Site 0705), Linz
Kepler Universitätsklinikum ( Site 0707), Linz
Medizinische Universitaet Innsbruck ( Site 0703), Innsbruck
Medizinische Universität Graz ( Site 0704), Graz
Chulabhorn Hospital ( Site 2305), Lak Si
Faculty of Medicine Siriraj Hospital ( Site 2304), Bangkok
Stony Brook University-Cancer Center ( Site 0013), Stony Brook
Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 0913, Berlin
CHUAC-Hospital Teresa Herrera-MEDICAL ONCOLOGY ( Site 1106), A Coruña
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0012), Lancaster
Trakya University-Medical Oncology ( Site 1203), Edirne
University of Virginia Cancer Center ( Site 0018), Charlottesville
Universitätsklinikum Schleswig-Holstein-Pneumologie ( Site 0902), Lübeck
CENTRO DE INFUSION E INVESTIGACION ONCOLOGIA DE SALTILLO S.C. ( Site 0304), Saltillo
Hospital Clinico San Carlos-Oncology Department ( Site 1107), Madrid
Charleston Oncology ( Site 0019), Charleston
Mayo Clinic in Florida ( Site 0022), Jacksonville
Acibadem Altunizade Hospital-Oncology ( Site 1207), Üsküdar / Stanbul
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1209), Istanbul
Umraniye Training and Research Hospital-medical oncology ( Site 1206), Istanbul
Hospital Insular de Gran Canaria-Oncology ( Site 1102), Las Palmas de Gran Canaria
Chungnam national university hospital-Department of Internal Medicine ( Site 2203), Daejeon
UKGM Gießen/Marburg-Medical Clinic V ( Site 0912), Giessen
Faculty of Medicine - Khon Kaen University ( Site 2303), Muang
China Medical University Hospital ( Site 2253), Taichung
Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 1103), Seville
Kyungpook National University Chilgok Hospital-Pulmonology ( Site 2202), Deagu
GEFOS Gesellschaft f. onkologische Studien ( Site 0909), Dortmund
Hospital Civil Fray Antonio Alcalde ( Site 0307), Guadalajara
CENTRE HOSPITALIER REGIONAL D'ORLEANS-Service de Pneumologie ( Site 0806), Orléans
Institut de Cancérologie de l'Ouest ( Site 0802), Angers
Pusan National University Hospital ( Site 2205), Busan
Cancer and Hematology Centers of Western Michigan ( Site 0002), Grand Rapids
Hospital Clínico Universitario Lozano Blesa-Oncology ( Site 1105), Zaragoza
Maharaj Nakorn Chiang Mai Hospital-Chiang Mai Clinical Trial Unit (CM-CTU) ( Site 2301), Chiang Mai
Mayo Clinic in Rochester, Minnesota ( Site 0030), Rochester
Chonnam National University Hwasun Hospital-Pulmonology ( Site 2201), Hwasun
Centre Hospitalier Regional Universitaire de Lille - Hôpital-Service de pneumologie et oncologie th, Lille
Mount Sinai Hospital ( Site 0011), Chicago
University of Chicago Medical Center ( Site 0015), Chicago
CENTRE LEON BERARD ( Site 0803), Lyon
Centre Hospitalier d'Annecy ( Site 0807), Epagny Metz-Tessy
University of Colorado Health - Harmony-Cancer Care and Hematology - Ft. Collins ( Site 0031), Fort Collins
UCHealth Memorial Hospital-Heme Onc ( Site 0003), Colorado Springs
Centre Hospitalier d'Avignon ( Site 0810), Avignon
Songklanagarind hospital ( Site 2302), Hat Yai
Beijing Cancer hospital-Thoracic Cancer Department A ( Site 2602), Beijing
Administradora Country S.A. - Clinica del Country ( Site 0601), Bogotá
Jilin Cancer Hospital-oncology department ( Site 2603), Changchun
Harbin Medical University Cancer Hospital-oncology of department ( Site 2604), Harbin
Sociedad De Oncologia Y Hematologia Del Cesar ( Site 0606), Valledupar
Fudan University Shanghai Cancer Center ( Site 2616), Shanghai
Shanghai Pulmonary Hospital-Oncology Department ( Site 2601), Shanghai
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology (, Nanjing
Oncomedica S.A.-Oncomedica S.A ( Site 0609), Montería
Anhui Provincil Hospital South District-Respiratory Medicine Dept ( Site 2619), Hefei
Shandong Cancer Hospital-Oncology Department ( Site 2630), Jinan
Tianjin Medical University Cancer Institute and Hospital-lung cancer ( Site 2606), Tianjin
The First Affiliated Hospital, Zhejiang University-Respiratory Department ( Site 2613), Hangzhou
Sir Run Run Shaw Hospital-Medical Oncology ( Site 2615), Hangzhou
Zhejiang Cancer Hospital-Oncology ( Site 2612), Hangzhou
The Second Affiliated hospital of Zhejiang University school of medicine-Respiratory Medicine ( Site, Hangzhou
The First Affiliated Hospital of Nanchang University-Respiratory Medicine Department ( Site 2625), Nanchang
The Second Affiliated Hospital of Nanchang University-Oncology Department ( Site 2624), Nanchang
Fujian Provincial Cancer Hospital-oncology department ( Site 2621), Fuzhou
The First Affiliated hospital of Xiamen University ( Site 2626), Xiamen
Xiangya Hospital Central South University-Oncology department ( Site 2627), Changsha
The Second Xiangya Hospital of Central South University ( Site 2623), Changsha
Hunan Cancer Hospital ( Site 2622), Changsha
Wuhan Union Hospital Cancer Center-Cancer Center ( Site 2618), Wuhan
Tongji Hospital Tongji Medical,Science & Technology ( Site 2617), Wuhan
Henan Cancer Hospital ( Site 2608), Zhengzhou
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine (, Guangzhou
Sichuan Cancer hospital ( Site 2628), Chengdu
West China Hospital of Sichuan University ( Site 2610), Chengdu
The Second People's Hospital of Yibin ( Site 2629), Yibin
Oncologos del Occidente ( Site 0608), Pereira
The First Affiliated Hospital of Xi'an Jiaotong University-Oncology ( Site 2607), Xi'an
Centro de Investigación Oncológica del Norte ( Site 0504), Antofagasta
Showa University Hospital ( Site 2403), Shinagawa
ONCOCENTRO APYS-ACEREY ( Site 0503), Viña del Mar
Rambam Health Care Campus-Oncology ( Site 1303), Haifa
Biocenter ( Site 0514), Concepción
Meir Medical Center-oncology ( Site 1301), Kfar Saba
James Lind Centro de Investigación del Cáncer ( Site 0502), Temuco
CIDO SpA-Oncology ( Site 0508), Temuco
Sheba Medical Center-ONCOLOGY ( Site 1302), Ramat Gan
Sourasky Medical Center-Oncology ( Site 1305), Tel Aviv
FALP-UIDO ( Site 0505), Santiago
Centro de Oncología de Precisión ( Site 0515), Santiago
Bradfordhill ( Site 0510), Santiago
Shaare Zedek Medical Center-Oncology ( Site 1306), Jerusalem
New England Cancer Specialists ( Site 0008), Scarborough
Centro de Oncología e Investigación de Buenos Aires ( Site 0203), Berazategui
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0204), Mar del Plata
Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0209), ABB
Centro de Educación Médica e Investigaciones Clínicas (CEMIC)-Medical Oncology ( Site 0202), Buenos Aires
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0206), La Rioja
Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 0403), Natal
Hospital Nossa Senhora da Conceição-Centro Integrado de Pesquisa em Oncologia ( Site 0405), Porto Alegre
Clínica de Oncologia Reichow ( Site 0407), Blumenau
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA ( Site 0406), Rio de Janeiro
Hospital Paulistano ( Site 0401), São Paulo
Fundación Colombiana de Cancerología Clínica Vida ( Site 0603), Medellín
HIA Sainte Anne ( Site 0804), Toulon
SRH Wald-Klinikum Gera ( Site 0911), Gera
National Hospital Organization Shikoku Cancer Center ( Site 2414), Matsuyama
Ehime University Hospital ( Site 2411), Tōon
Hyogo Cancer Center-Thoracic Oncology ( Site 2409), Akashi
Kanazawa University Hospital ( Site 2407), Kanazawa
Kanagawa cancer center-Department of Thoracic Oncology ( Site 2405), Yokohama
Miyagi Cancer Center ( Site 2401), Natori-shi
Kansai Medical University Hospital ( Site 2415), Hirakata
Saitama Prefectural Cancer Center ( Site 2406), Ina-machi
Shizuoka Cancer Center ( Site 2408), Nakatogari
Japanese Foundation for Cancer Research ( Site 2402), Koto
National Hospital Organization Kyushu Medical Center ( Site 2413), Fukuoka
National Hospital Organization Kyushu Cancer Center ( Site 2412), Fukuoka
Okayama University Hospital ( Site 2410), Okayama
Nippon Medical School Hospital ( Site 2404), Tokyo
Arké SMO S.A. de C.V. ( Site 0301), Mexico City
Alivia Clínica de Alta Especialidad ( Site 0310), Mexico City
Przychodnia Lekarska KOMED ( Site 1902), Konin
Med-Polonia Sp. z o. o. ( Site 1909), Poznan
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1903), Bydgoszcz
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier, Warsaw
Centrum Medyczne Ostrobramska NZOZ Magodent ( Site 1908), Warsaw
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1904), Przemyśl
Szpital Specjalistyczny w Prabutach Spolka z o.o. ( Site 1906), Prabuty
Centrum Pulmonologii i Torakochirurgii w Bystrej ( Site 1907), Bystra
Asan Medical Center ( Site 2206), Songpa-gu
Korea University Guro Hospital-Internal Medicine ( Site 2204), Seoul
Leicester Royal Infirmary-HOPE Clinical Trials Unit ( Site 1502), Leicester
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1101), Barcelona
Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1208), Adana
Hacettepe Universitesi-oncology hospital ( Site 1202), Ankara
Liv Hospital Ankara-Oncology ( Site 1205), Ankara
Ankara City Hospital ( Site 1204), Ankara
Chelsea and Westminster Hospital NHS Foundation Trust-Research and Development ( Site 1501), London
St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 1506), London
University College London Hospital-Cancer Clinical Trials Unit ( Site 1509), London-Camden
Merck Sharp & Dohme LLC
INDUSTRY